Akçimen F, Lopez ER, Landers JE, Nath A, Chiò A, Chia R et al (2023) Amyotrophic lateral sclerosis: translating genetic discoveries into therapies. Nat Rev Genet 24(9):642–658. https://doi.org/10.1038/s41576-023-00592-y

Article  PubMed  PubMed Central  CAS  Google Scholar 

Potenza RL, Armida M, Popoli P (2024) Can some anticancer drugs be repurposed to treat amyotrophic lateral sclerosis? A brief narrative review. Int J Mol Sci 25(3):1751. https://doi.org/10.3390/ijms25031751

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abati E, Bresolin N, Comi G, Corti S (2020) Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS). Expert Opin Ther Targets 24(4):295–310. https://doi.org/10.1080/14728222.2020.1738390

Article  PubMed  CAS  Google Scholar 

Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ (2023) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov 22(3):185–212. https://doi.org/10.1038/s41573-022-00612-2

Article  PubMed  CAS  Google Scholar 

Izenberg A (2023) Amyotrophic lateral sclerosis and other motor neuron diseases. Continuum (Minneap Minn) 29(5):1538–1563. https://doi.org/10.1212/CON.0000000000001345

Article  PubMed  Google Scholar 

Gerritzen EV, Lee AR, McDermott O, Coulson N, Orrell M (2024) Online peer support for people with amyotrophic lateral sclerosis (ALS): a narrative synthesis systematic review. Front Digit Health 6:1138530. https://doi.org/10.3389/fdgth.2024.1138530

Article  PubMed  PubMed Central  Google Scholar 

Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC et al (2022) Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol 21(5):465–479. https://doi.org/10.1016/S1474-4422(21)00414-2

Article  PubMed  CAS  Google Scholar 

Wimmer T, Schreiber F, Hensiek N, Garz C, Kaufmann J, Machts J et al (2020) The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI. Sci Rep 10(1):1783. https://doi.org/10.1038/s41598-020-58687-z

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tamaki Y, Ross JP, Alipour P, Castonguay C-É, Li B, Catoire H et al (2023) Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids. PLoS Genet 19(2):e1010606. https://doi.org/10.1371/journal.pgen.1010606

Article  PubMed  PubMed Central  CAS  Google Scholar 

Davis DA, Cox PA, Banack SA, Lecusay PD, Garamszegi SP, Hagan MJ et al (2020) l-Serine reduces spinal cord pathology in a vervet model of preclinical ALS/MND. J Neuropathol Exp Neurol 79(4):393–406. https://doi.org/10.1093/jnen/nlaa002

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ et al (2022) Amyotrophic lateral sclerosis. Lancet 400(10360):1363–1380. https://doi.org/10.1016/S0140-6736(22)01272-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Witzel S, Mayer K, Oeckl P (2022) Biomarkers for amyotrophic lateral sclerosis. Curr Opin Neurol 35(5):699–704. https://doi.org/10.1097/WCO.0000000000001094

Article  PubMed  Google Scholar 

Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A et al (2017) Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort. J Neurol 264(11):2224–2231. https://doi.org/10.1007/s00415-017-8619-4

Article  PubMed  Google Scholar 

Reyes-Leiva D, Dols-Icardo O, Sirisi S, Cortés-Vicente E, Turon-Sans J, de Luna N et al (2022) Pathophysiological underpinnings of extra-motor neurodegeneration in amyotrophic lateral sclerosis: new insights from biomarker studies. Front Neurol. https://doi.org/10.3389/fneur.2021.750543

Article  PubMed  PubMed Central  Google Scholar 

Corcia P, Lunetta C, Vourc’h P, Pradat PF, Blasco H (2023) Time for optimism in amyotrophic lateral sclerosis. Eur J Neurol 30(5):1459–1464. https://doi.org/10.1111/ene.15738

Article  PubMed  Google Scholar 

Wang JC, Ramaswami G, Geschwind DH (2021) Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility. Sci Rep 11(1):5748. https://doi.org/10.1038/s41598-021-85061-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kumar V, Kashav T, Hassan MI (2019) Amyotrophic lateral sclerosis: current therapeutic perspectives. In: Singh S, Joshi N (eds) Pathology, prevention and therapeutics of neurodegenerative disease. Springer, Singapore, pp 207–224. https://doi.org/10.1007/978-981-13-0944-1_19

Chapter  Google Scholar 

Spoden C, Wenzel O, Erdmann A, Neitzke G, Hirschberg I (2024) Coping and end-of-life decision-making in ALS: a qualitative interview study. PLoS ONE 19(6):e0306102. https://doi.org/10.1371/journal.pone.0306102

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ et al (2022) Amyotrophic lateral sclerosis. The Lancet 400(10360):1363–1380. https://doi.org/10.1016/S0140-6736(22)01272-7

Article  CAS  Google Scholar 

Corcia P, Beltran S, Bakkouche SE, Couratier P (2021) Therapeutic news in ALS. Revue Neurologique 177(5):544–549. https://doi.org/10.1016/j.neurol.2020.12.003

Article  PubMed  CAS  Google Scholar 

Andrews JA, Jackson CE, Heiman-Patterson TD, Bettica P, Brooks BR, Pioro EP (2020) Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotroph Later Scler Frontotemporal Degener 21(7–8):509–518. https://doi.org/10.1080/21678421.2020.1771734

Article  CAS  Google Scholar 

Merjane J, Chung R, Patani R, Lisowski L (2023) Molecular mechanisms of amyotrophic lateral sclerosis as broad therapeutic targets for gene therapy applications utilizing adeno-associated viral vectors. Med Res Rev 43(4):829–854. https://doi.org/10.1002/med.21937

Article  PubMed  CAS  Google Scholar 

Soares P, Silva C, Chavarria D, Silva FSG, Oliveira PJ, Borges F (2023) Drug discovery and amyotrophic lateral sclerosis: emerging challenges and therapeutic opportunities. Ageing Res Rev 83:101790. https://doi.org/10.1016/j.arr.2022.101790

Article  PubMed  CAS  Google Scholar 

Giovannelli I, Higginbottom A, Kirby J, Azzouz M, Shaw PJ (2023) Prospects for gene replacement therapies in amyotrophic lateral sclerosis. Nat Rev Neurol 19(1):39–52. https://doi.org/10.1038/s41582-022-00751-5

Article  PubMed  CAS  Google Scholar 

Lejman J, Panuciak K, Nowicka E, Mastalerczyk A, Wojciechowska K, Lejman M (2023) Gene therapy in ALS and SMA: advances, challenges and perspectives. Int J Mol Sci 24(2):1130. https://doi.org/10.3390/ijms24021130

Article  PubMed  PubMed Central  CAS  Google Scholar 

Berdigaliyev N, Aljofan M (2020) An overview of drug discovery and development. Future Med Chem 12(10):939–947. https://doi.org/10.4155/fmc-2019-0307

Article  PubMed  CAS  Google Scholar 

Wei C, Zhu Y, Li S, Chen W, Li C, Jiang S et al (2022) Identification of an immune-related gene prognostic index for predicting prognosis, immunotherapeutic efficacy, and candidate drugs in amyotrophic lateral sclerosis. Front Cell Neurosci 16:993424. https://doi.org/10.3389/fncel.2022.993424

Article  PubMed  PubMed Central  CAS  Google Scholar